Sorrento Therapeutics Inc. (SRNE) Fundamentals

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for the treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody-drug conjugates.
SHARE INFORMATION
Market Cap$ 610,645,931
Shares Outstanding388,946,453
Float384,456,190
Percent Float98.85%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 52,904,000
Latest Fiscal EPS$ -1.43
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions423
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months14,196,564
Institutional Holdings Percent58.9%
Institutional Sold Previous 3 Months5,754,851
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent30.5
Insider Sold Previous 3 Months-
Insider Shares Owned104,756,180
TRADING INFO
52 Week High$ 11.07
52 Week Low$ 1.15
52 Week High Change$ -76.39
21 Day Moving Average$ 1.5729
21 Day Extended Moving Average$ 1.5984
50 Day Moving Average$ 1.9646
50 Day Extended Moving Average$ 2.0158
200 Day Moving Average$ 5.0005
200 Day Extended Moving Average$ 4.3351
10 Day Average Volume9,417,695
20 Day Average Volume10,101,659
30 Day Average Volume9,374,014
50 Day Average Volume10,097,277
Alpha0.028353
Beta2.4292
Standard Deviation0.391142
R20.086430
7 Day Price Change$ 0.15
7 Day Percent Change10.56%
21 Day Price Change$ -0.03
21 Day Percent Change-1.88%
30 Day Price Change$ -0.32
30 Day Percent Change-16.93%
Month to Date Price Change$ 0.06
Month to Date Percent Change3.97%
Quarter to Date Price Change$ -0.76
Quarter to Date Percent Change-32.62%
180 Day Price Change$ -4.63
180 Day Percent Change-74.68%
200 Day Price Change$ -5.29
200 Day Percent Change-77.11%
Year to Date Price Change$ -3.08
Year to Date Percent Change-66.24%

Sorrento Therapeutics Inc. (SRNE) Key Ratios

PROFITABILITY
EBIT Margin-864.4%
EBITDA Margin-841.9%
Pre-Tax Profit Margin-856.2%
Profit Margin Count0.0%
Gross Margin73.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 57,034,000
Revenue Per Share$ 0.1466
Revenue (3 Years)$ 31.39
Revenue (5 Years)$ 8.24
FINANCIAL STRENGTH
Price to Tangible Book-5.00
Total Debt To Equity1.10
Int Coverage-44.40
Current Ratio1.60
Leverage Ratio4.90
Quick Ratio1.40
Long Term Debt To Capital0.44
VALUATION MEASURES
PE Ratio-0.90
Enterprise Value$ 538,309,892
Price to Sales10.7067
Price to Free Cash-1.50
PE High Last 5 Years266.30
Price To Book2.50
Price To Cash Flow0.00
PE Low Last 5 Years-3.60
Price to Tangible Book-5.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.90
Invoice Turnover0.80
Assets Turnover0.10
Return Assets-65.73
Return on Equity-211.94
Return on Capital-107.06

Sorrento Therapeutics Inc. (SRNE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOHenry Ji
Emplyoees799
Last AuditUE
CIK0000850261
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address4955 Directors Place
San Diego, CA 92121
Websitehttps://www.sorrentotherapeutics.com
Facsimile+1 858 203-4028
Telephone+1 858 203-4100
Emailinvestors@sorrentotherapeutics.com


Your Recent History
NASDAQ
SRNE
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.